Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF

Healthcare Biotechnology


GREY:IPHAF - Post by User

Isotechnika Pharma Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by professional11on Jan 21, 2010 3:39pm
406 Views
Post# 16705195

Pertinent news for Voclosporine Lux-ISA

Pertinent news for Voclosporine Lux-ISA

Inspire's Prolacria Fails in Phase III Dry Eye Study

Shares of Inspire Pharmaceuticals Inc. were down 12 % at noon trading on news that its Phase III study of Prolacria in dry eye disease missed both primary and secondary endpoints. Inspire said it will review the program with partner Allergan Inc., but the latest miss could mean the end of Prolacria, which has twice received approvable letters in dry eye.

P11

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities